FrancophonIA/ELRC3.0 huggingface dataset:
English: Urinary concentrations of the bone resorption marker CTx (C-terminal telopeptide released from Type I collagen) were significantly reduced in the Bondronat group compared to placebo.
Croatian: Koncentracije biljega resorpcije kostiju CTx (C-terminalni telopeptid otpušten iz kolagena tipa I) u urinu bile su znatno smanjene u grupi koja je primala Bondronat u usporedbi s placebo grupom.
English: • a skin growth called a ‘benign skin neoplasm”
Croatian: • izraslina na koži zvana “dobroćudna novotvorina kože“
English: • Stay upright (sitting or standing) while taking your tablet and for the next hour (60 minutes).
Croatian: • Budite u uspravnom položaju (sjedeći ili stojeći) dok uzimate tabletu te još jedan sat (60 minuta) nakon uzimanja tablete.
English: Medicinal product -Food Interactions
Croatian: Interakcije lijeka i hrane
English: Female patients with breast cancer and radiologically confirmed bone metastases were randomised to receive placebo (277 patients) or 50 mg Bondronat (287 patients).
Croatian: Bolesnice s rakom dojke i radiološki potvrđenim koštanim metastazama randomizirane su za primanje placeba (277 bolesnica) ili 50 mg lijeka Bondronat (287 bolesnica).
English: INFORMATION IN BRAILLE Justification for not including Braille accepted
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Prihvaćeno obrazloženje za nenavođenje Braillea
English: This is because aminoglycosides and Bondronat can both lower the amount of calcium in your blood.
Croatian: To je važno stoga što i aminoglikozidi i Bondronat mogu smanjiti razine kalcija u krvi.
English: The recommended dose is one 50 mg film-coated tablet daily.
Croatian: Doziranje Preporučena je doza jedna 50 mg filmom obložena tableta dnevno.
English: • flu-like symptoms, including fever, shaking and shivering, feeling of discomfort, fatigue, bone pain and aching muscles and joints.
Croatian: • simptomi nalik gripi, uključujući vrućicu, tresavicu i drhtanje, osjećaj nelagode, umor, bol u kostima, mišićima i zglobovima.
English: Sodium acetate, sodium chloride, acetic acid and water for injections.
Croatian: Natrijev acetat, natrijev klorid, acetatna kiselina i voda za injekcije.
English: • you have any problems with your mouth or teeth such as poor dental health, gum disease, or a planned tooth extraction
Croatian: • ako imate bilo kakvih tegoba s ustima ili zubima, poput lošeg zdravlja zubi ili bolesti desni, ili ako planirate vaditi zub
English: - Treatment of tumour-induced hypercalcaemia with or without metastases
Croatian: - liječenje hiperkalcijemije nastale kao posljedica tumora s metastazama ili bez njih
English: Atypical subtrochanteric and diaphyseal femoral fractures have been reported with bisphosphonate therapy, primarily in patients receiving long-term treatment for osteoporosis.
Croatian: Atipična suptrohanterična dijafizealna fraktura femura zabilježena je kod liječenja bisfosfonatima, prvenstveno u bolesnika koji su dugotrajno primali lijekove protiv osteoporoze.
English: Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Bondronat is given to patients with active upper gastrointestinal problems (e.g. known Barrett's oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Croatian: Zbog pojave ovih mogućih iritacija i mogućnosti pogoršanja osnovne bolesti, potreban je oprez kad se Bondronat propisuje bolesnicima s problemima gornjeg dijela gastrointestinalnog sustava (na primjer Barrettov jednjak, disfagija, druge bolesti jednjaka, gastritis, upala dvanaesnika ili vrijedovi).
English: As no clinical data are available, dose recommendations cannot be given for patients with severe hepatic insufficiency (see section 4.2).
Croatian: Budući da nisu dostupni klinički podaci, ne mogu se dati preporuke za doziranje u bolesnika s teškim oštećenjem jetre (vidjeti dio 4.2).
English: LIST OF EXCIPIENTS The tablets also contain lactose monohydrate.
Croatian: POPIS POMOĆNIH TVARI Tablete također sadrže laktozu hidrat.
English: Bondronat is indicated in adults for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
Croatian: Bondronat je indiciran u odraslih za sprječavanje koštanih poremećaja (patološki prijelomi, komplikacije na kostima koje zahtijevaju radioterapiju ili operaciju) u bolesnika s rakom dojke i koštanim metastazama.
English: In subjects with severe renal impairment (mean estimated CLcr = 21.2 mL/min), dose-adjusted mean AUC0-24h was increased by 110% compared to healthy volunteers.
Croatian: Kod bolesnika s teškim oštećenjem bubrega (srednja procijenjena vrijednost CLcr = 21,2 ml/min), srednja vrijednost AUC0-24h prilagođena dozi, je bila povećana za 110% u odnosu na zdrave dobrovoljce.
English: • Do not use this medicine after the expiry date which is stated on the folding box and on the label after EXP.
Croatian: • Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici bočice iza oznake „Rok valjanosti“ ili „EXP“.
English: Patients with cardiac impairment Overhydration should be avoided in patients at risk of cardiac failure.
Croatian: Bolesnici s oštećenjem srca Treba izbjegavati prekomjernu hidraciju u bolesnika u kojih postoji opasnost od zatajenja srca.
English: Bondronat contains less than 1 mmol sodium (23 mg) per vial, i.e. ‘essentially sodium free'.
Croatian: Bondronat sadrži manje od 1 mmol natrija (23 mg) po bočici, odnosno zanemarive količine natrija.
English: • a problem with your eyes called ‘cataracts'
Croatian: • problem s očima zvan „očna mrena“
English: In healthy male volunteers and postmenopausal women, intravenous ranitidine caused an increase in ibandronic acid bioavailability of about 20% (which is within the normal variability of the bioavailability of ibandronic acid), probably as a result of reduced gastric acidity.
Croatian: H2-antagonisti ili drugi lijekovi koji povisuju pH želučane kiseline U zdravih muških ispitanika i žena u postmenopauzi intravenski ranitidin uzrokovao je povećanje bioraspoloživosti ibandronatne kiseline za otprilike 20% (što je u okviru normalne varijabilnosti bioraspoloživosti ibandronatne kiseline), vjerojatno kao rezultat smanjene kiselosti želuca.
English: Calcium containing solutions should not be mixed with Bondronat concentrate for solution for infusion.
Croatian: Otopine koje sadrže kalcij ne smiju se miješati s Bondronat koncentratom za otopinu za infuziju.
English: ≥50 CLcr<80 6 mg (6 ml of concentrate for solution for infusion)
Croatian: ≥50 klirens kreatinina<80 6 mg (6 ml koncentrata za otopinu za infuziju)
English: What Bondronat looks like and contents of the pack The film-coated tablets are of oblong shape and white to off-white in colour, engraved L2/IT.
Croatian: Bondronat filmom obložene tablete ovalnog su oblika i bijele do bjelkaste boje, a na njima je utisnuto L2/IT.
English: • The other ingredients are sodium chloride, acetic acid, sodium acetate and water for injections
Croatian: • Drugi sastojci su natrijev klorid, acetatna kiselina, natrijev acetat i voda za injekcije.
English: Then you can have your first food and drink, and take any medicines or supplements
Croatian: Nakon toga možete uzeti svoj prvi jutarnji obrok, piće i druge lijekove ili nadomjesne pripravke.
English: Paediatric population (see section 4.2 and section 5.2) The safety and efficacy of Bondronat in children and adolescents below the age of 18 years have not been established.
Croatian: Pedijatrijska populacija (vidjeti dijelove 4.2 i 5.2) Sigurnost i djelotvornost lijeka Bondronat u djece i adolescenata mlađih od 18 godina nisu ustanovljene.
English: - radiotherapy to bone for treatment of fractures/impending fractures - surgery to bone for treatment of fractures - vertebral fractures - non-vertebral fractures
Croatian: - radioterapija kostiju radi liječenja prijeloma/mogućih prijeloma - operacija kostiju zbog liječenja prijeloma - prijelomi kralježnice - drugi prijelomi osim kralježnice.
English: For patients with severe renal impairment (CLcr <30 mL/min) the recommended dose is one 50 mg film-coated tablet once weekly.
Croatian: Za bolesnike s teškim oštećenjem bubrega (klirens kreatinina < 30 ml/min) preporučena doza je jedna 50 mg filmom obložena tableta jedanput tjedno.
English: Cerebrovascular disorder, nerve root lesion, amnesia, migraine, neuralgia, hypertonia, hyperaestesia, paraesthesia circumoral, parosmia
Croatian: cerebrovaskularni poremećaj, oštećenje korijena živca, amnezija, migrena, neuralgija, hipertonija, hiperestezija, cirkumolarna parestezija, parosmija
English: Patients with disturbances of bone and mineral metabolism Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Bondronat therapy.
Croatian: Bolesnici s poremećajima metabolizma kosti i minerala Hipokalcijemiju i ostale poremećaje metabolizma kostiju i minerala potrebno je učinkovito liječiti prije početka terapije lijekom Bondronat.
English: • if you have problems with your food pipe/gullet (oesophagus) such as narrowing or difficulty swallowing
Croatian: • ako imate probleme s jednjakom (ezofagusom), kao što su suženje ili teškoće prilikom gutanja
English: All patients should be encouraged to maintain good oral hygiene, undergo routine dental check-ups, and immediately report any oral symptoms such as dental mobility, pain or swelling, or non-healing of sores or discharge during treatment with Bondronat.
Croatian: Sve bolesnike treba potaknuti da tijekom liječenja lijekom Bondronat održavaju dobru oralnu higijenu, redovito odlaze na kontrolne stomatološke preglede i odmah prijave sve oralne simptome poput pomicanja zuba, boli ili oticanja, rana koje ne cijele ili iscjetka.
English: If you have a raised calcium level in your blood due to a tumour,then the recommended dose is a single administration of 2 mg or 4 mg depending on the severity of your illness.
Croatian: Ako imate povišenu razinu kalcija u krvi uzrokovanu tumorom, tada je preporučena doza jednokratna primjena 2 mg ili 4 mg, ovisno o težini bolesti.
English: Film-coated tablets.
Croatian: Filmom obložene tablete.
English: The pain reduction was consistently below baseline throughout the entire study and accompanied by a significantly reduced use of analgesics.
Croatian: Smanjenje boli bilo je tijekom cjelokupnog ispitivanja ispod početne vrijednosti i praćeno značajno smanjenom uporabom analgetika.
English: SPECIAL STORAGE CONDITIONS Store in the original package in order to protect from moisture
Croatian: POSEBNE MJERE ČUVANJA Čuvati u originalnom pakiranju radi zaštite od vlage
English: Table 1 lists adverse drug reactions from the pivotal phase III studies (Treatment of tumour induced hypercalcaemia: 311 patients treated with Bondronat 2 mg or 4 mg; Prevention of skeletal events in patients with breast cancer and bone metastases: 152 patients treated with Bondronat 6 mg), and from post-marketing experience.
Croatian: Tablici 1 popisane su nuspojave iz pivotalnih ispitivanja faze III (Liječenje hiperkalcijemije uzrokovane tumorom: 311 bolesnika liječenih lijekom Bondronat u dozi od 2 mg ili 4 mg; Sprječavanje koštanih događaja u bolesnika s rakom dojke i koštanim metastazama: 152 bolesnika liječena lijekom Bondronat u dozi od 6 mg) i iz iskustva nakon stavljanja lijeka na tržište.
English: Patients treated with Bondronat should be given the package leaflet and the patient reminder card.
Croatian: Bolesnici koji se liječe lijekom Bondronat moraju dobiti uputu o lijeku i karticu s podsjetnikom za bolesnike.
English: Subjects with severe renal impairment (CLcr  30 mL/min) receiving oral administration of 10 mg ibandronic acid daily for 21 days, had 2-3 fold higher plasma concentrations than subjects with normal renal function (CLcr ≥80 mL/min).
Croatian: Bolesnici s teškim oštećenjima bubrega (CLcr ≤30 ml/min) koji su peroralno uzimali 10 mg ibandronatne kiseline svakodnevno u razdoblju od 21 dan, imali su dvostruko do trostruko više koncentracije u plazmi od osoba s normalnom funkcijom bubrega (CLcr ≥80 ml/min).
English: The number of SREs was also significantly reduced with Bondronat 6 mg and there was a 40% reduction in the risk of a SRE over placebo (relative risk 0.6, p = 0.003).
Croatian: Broj SRE bio je također znatno smanjen uz Bondronat 6 mg, sa 40% smanjenim rizikom od pojave SRE u usporedbi s placebom (relativni rizik 0,6; p = 0,003).
English: Hypersensitivity†, bronchospasm†, angioedema†, Anaphylactic reaction/shock†**
Croatian: Poremećaji imunološkog sustava preosjetljivost†, bronhospazam†, angioedem†, anafilaktička reakcija/šok†**
English: Bondronat should not be used during breast-feeding.
Croatian: Bondronat se ne smije koristiti za vrijeme dojenja.
English: - Prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases
Croatian: - sprječavanje koštanih poremećaja (patološki prijelomi, komplikacije na kostima koje zahtijevaju radioterapiju ili operaciju) u bolesnika s rakom dojke i koštanim metastazama
English: PHARMACEUTICAL FORM AND CONTENTS Concentrate for solution for infusion 1 vial
Croatian: OBLIK I SADRŽAJ Koncentrat za otopinu za infuziju 1 bočica
English: Ocular inflammation events such as uveitis, episcleritis and scleritis have been reported with ibandronic acid.
Croatian: Događaji povezani s upalom oka poput uveitisa, episkleritisa ili skleritisa zabilježeni su uz primjenu ibandronatne kiseline.
English: Injury, poisoning and procedural complications
Croatian: Ozljede, trovanja i proceduralne komplikacije ozljeda, bol na mjestu primjene
English: Drink a full glass of milk before you go. Do not make yourself sick.
Croatian: Prije nego krenete, popijte punu šalicu mlijeka.
English: Patients with disturbances of bone and mineral metabolism Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Bondronat therapy for metastatic bone disease.
Croatian: Bolesnici s poremećajima metabolizma kosti i minerala Hipokalcijemiju i ostale poremećaje metabolizma kostiju i minerala potrebno je učinkovito izliječiti prije početka liječenja metastatske bolesti kostiju lijekom Bondronat.
English: What Bondronat is and what it is used for What you need to know before you receive Bondronat How to receive Bondronat
Croatian: Što je Bondronat i za što se koristi Što morate znati prije nego počnete uzimati Bondronat Kako uzimati Bondronat
English: If you have breast cancer that has spread to your bones, then the recommended dose is 3 vials (6 mg) every 3-4 weeks, as an infusion in your vein over at least 15 minutes.
Croatian: Ako imate rak dojke koji se proširio na kosti, preporučena doza je 3 bočice (6 mg) svaka 3-4 tjedna, u obliku infuzije u venu, u trajanju od najmanje 15 minuta.
English: • tablet core: lactose monohydrate, povidone, microcrystalline cellulose, crospovidone, purified stearic acid, colloidal anhydrous silica
Croatian: • jezgra tablete: laktoza hidrat, povidon, mikrokristalična celuloza, krospovidon, stearatna kiselina, koloidni bezvodni silicijev dioksid.
English: Additional risk minimisation measures The MAH shall ensure that a patient reminder card regarding osteonecrosis of the jaw is implemented.
Croatian: Nositelj odobrenja osigurat će implementaciju kartice s podsjetnikom za bolesnike o osteonekrozi čeljusti.
English: A 15 minute infusion time has not been studied in cancer patients with a creatinine clearance of <50ml/min.
Croatian: Nije provedeno ispitivanje 15-minutne infuzije u bolesnika oboljelih od raka s klirensom kreatinina < 50 ml/min.
English: Table 1 lists adverse reactions from 2 pivotal phase III studies (Prevention of skeletal events in patients with breast cancer and bone metastases: 286 patients treated with Bondronat 50 mg administered orally), and from post-marketing experience.
Croatian: Tablici 1 popisane su nuspojave iz 2 pivotalna ispitivanja faze III (Sprječavanje koštanih događaja u bolesnika s rakom dojke i koštanim metastazama: 286 bolesnika liječena lijekom Bondronat od 50 mg primijenjim peroralno) i iz iskustva nakon stavljanja lijeka na tržište.
English: Stevens-Johnson Syndrome†, Erythema Multiforme†, Dermatitis Bullous†
Croatian: Stevens-Johnsonov sindrom†, multiformni eritem†, bulozni dermatitis†
English: Dosage: Treatment of Tumour-induced Hypercalcaemia Bondronat is usually administered in a hospital setting.
Croatian: Doziranje: Liječenje hiperkalcijemije nastale zbog tumora Bondronat se obično primjenjuje u bolničkim uvjetima.
English: If you have a raised calcium level in your blood due to a tumour then the recommended dose is a single administration of 1 vial (2 mg) or 2 vials (4 mg), depending on the severity of your illness.
Croatian: Ako imate povišenu razinu kalcija u krvi uzrokovanu tumorom, tada je preporučena doza jednokratna primjena 1 bočice (2 mg) ili 2 bočice (4 mg), ovisno o težini bolesti.
English: NAME OF THE MEDICINAL PRODUCT Bondronat 50 mg film-coated tablets.
Croatian: NAZIV LIJEKA Bondronat 50 mg filmom obložene tablete.
English: Sleep disorder, anxiety, affection lability
Croatian: Psihijatrijski poremećaji poremećaj spavanja, anksioznost, emocionalna labilnost
English: SMPR (per patient year)
Croatian: SMPR (po bolesnikgodini)
English: Talk to your doctor, pharmacist or nurse before receiving Bondronat:
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primite Bondronat:
English: StevensJohnson Syndrome†, Erythema Multiforme†, Dermatitis Bullous†
Croatian: StevensJohnsonov sindrom†, multiformni eritem†, bulozni dermatitis†
English: • feeling thirsty, sore throat, changes in taste
Croatian: • žeđ, grlobolja, promjene osjeta okusa
English: The following risk factors should be considered when evaluating a patient's risk of developing ONJ: - Potency of the medicinal product that inhibit bone resorption (higher risk for highly potent compounds), route of administration (higher risk for parenteral administration) and cumulative dose of bone resorption therapy - Cancer, co-morbid conditions (e.g. anaemia, coagulopathies, infection), smoking - Concomitant therapies: corticosteroids, chemotherapy, angiogenesis inhibitors, radiotherapy to head and neck - Poor oral hygiene, periodontal disease, poorly fitting dentures, history of dental disease, invasive dental procedures e.g. tooth extractions
Croatian: Pri ocjenjivanju bolesnikova rizika za razvoj osteonekroze čeljusti potrebno je razmotriti sljedeće faktore rizika: - potentnost lijeka koji inhibira koštanu resorpciju (veći rizik kod primjene visoko potentnih spojeva), put primjene (veći rizik kod parenteralne primjene) i kumulativnu dozu inhibitora koštane resorpcije - rak, popratna stanja (npr. anemija, koagulopatije, infekcija), pušenje - istodobno primijenjene terapije: kortikosteroidi, kemoterapija, inhibitori angiogeneze,
English: • sleep problems, feeling anxious, emotional instability, or mood swings
Croatian: • poremećaj spavanja, osjećaj tjeskobe, emotivna labilnost ili promjene raspoloženja
English: - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - Hypocalcaemia
Croatian: - Preosjetljivost na ibandronatnu kiselinu ili neku od pomoćnih tvari navedenih u dijelu 6.1. - Hipokalcijemija
English: Bondronat is used in adults and prescribed to you if you have breast cancer that has spread to your bones (called ‘bone‘metastases').
Croatian: Bondronat se koristi za liječenje odraslih bolesnika i bit će Vam propisan ako imate rak dojke koji se proširio na kosti (što se naziva „koštane metastaze“).
English: In order to avoid potential incompatibilities, Bondronat concentrate for solution for infusion should only be mixed with isotonic sodium chloride solution or with 5% dextrose solution.
Croatian: Da bi se izbjegle potencijalne inkompatibilnosti, Bondronat koncentrat za otopinu za infuziju smije se miješati samo izotoničnom otopinom natrijevog klorida ili 5%-tnom otopinom glukoze.
English: Bondronat contains the active substance ibandronic acid.
Croatian: Bondronat sadrži djelatnu tvar ibandronatnu kiselinu.
English: What you need to know before you receive Bondronat
Croatian: Što morate znati prije nego počnete primati Bondronat
English: There was a marked depression of urinary markers of bone resorption (pyridinoline and deoxypyridinoline) in patients treated with Bondronat that was statistically significant compared to placebo.
Croatian: U bolesnika liječenih lijekom Bondronat došlo je do značajnog pada biljega resorpcije kostiju u urinu (piridinolin i deoksipiridinolin) koji je bio statistički značajan u usporedbi s placebo grupom.
English: • It is given as an infusion into your vein
Croatian: • Primit ćete ga u obliku infuzije u venu.
English: What Bondronat is and what it is used for What you need to know before you take Bondronat How to take Bondronat
Croatian: Što je Bondronat i za što se koristi Što morate znati prije nego počnete primati Bondronat
English: Common (may affect up to 1 in 10 people): feeling sick, heartburn and discomfort in swallowing (inflammation of your gullet/ food pipe)
Croatian: Česte (mogu se javiti kod manje od 1 na 10 osoba): • mučnina, žgaravica i nelagoda pri gutanju (upala jednjaka)
English: After reconstitution: Store at 2°C - 8°C (in a refrigerator).
Croatian: Nakon rekonstitucije: čuvati na temperaturi 2°C - 8°C (u hladnjaku).
English: Bondronat works by reducing the amount of calcium that is lost from your bones.
Croatian: Bondronat djeluje tako da smanjuje gubitak kalcija iz kostiju.
English: NAME OF THE MARKETING AUTHORISATION HOLDER Atnahs Pharma Netherlands B.V.
Croatian: NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Atnahs Pharma Netherlands B.V.
English: Table 1 Adverse Drug Reactions Reported for Oral Administration of Bondronat System Organ
Croatian: Tablica 1 Nuspojave prijavljene uz peroralnu primjenu lijeka Bondronat Organski sustav
English: Care must be taken not to administer Bondronat concentrate for solution for infusion via intra-arterial or paravenous administration, as this could lead to tissue damage..
Croatian: Potreban je oprez kako se Bondronat koncentrat za otopinu za infuziju ne bi primijenio intraarterijski ili paravenski, jer to može dovesti do oštećenja tkiva.
English: Bondronat 50 mg film-coated tablets ibandronic acid
Croatian: Bondronat 50 mg filmom obložene tablete ibandronatna kiselina
English: Bondronat concentrate for solution for infusion should be administered as an intravenous infusion over 2 hours.
Croatian: Bondronat koncentrat za otopinu za infuziju mora se primijeniti intravenskom infuzijom u trajanju od 2 sata.
English: To avoid potential incompatibilities Bondronat concentrate for solution for infusion should only be diluted with isotonic sodium chloride solution or 5% glucose solution.
Croatian: Da bi se izbjegle potencijalne inkompatibilnosti, Bondronat koncentrat za otopinu za infuziju smije se razrijediti samo izotoničnom otopinom natrijevog klorida ili 5%-tnom otopinom glukoze.
English: For the prevention of skeletal events in patients with breast cancer and bone metastases, the Bondronat infusion is repeated at 3-4 week intervals.
Croatian: Za sprječavanje koštanih poremećaja u bolesnika s rakom dojke i koštanim metastazama, infuzija lijeka Bondronat ponavlja se u intervalima od 3 - 4 tjedna.
English: There is no evidence for clinically relevant interethnic differences between Asians and Caucasians in ibandronic acid disposition.
Croatian: Nema dokaza klinički značajnih međuetničkih razlike između azijata i bijelaca u izloženosti ibandronatnoj kiselini.
English: If you are not sure, talk to your doctor or pharmacist before taking Bondronat.
Croatian: Ako niste sigurni, obratite se svom liječniku ili ljekarniku prije nego uzmete Bondronat.
English: • After dilution the infusion solution is stable for 24 hours at 2-8°C (in a refrigerator)
Croatian: • Nakon razrjeđivanja, infuzijska otopina stabilna je 24 sata na temperaturi od 2-8 °C (u hladnjaku).
English: Talk to your doctor or pharmacist before taking Bondronat:
Croatian: Obratite se svom liječniku ili ljekarniku prije nego primite Bondronat: